A drug repurposing method based on inhibition effect on gene regulatory network

Area of Science:

• Computational biology
• Pharmacology
• Bioinformatics

Background:

• Traditional drug discovery is expensive and slow.
• Existing computational drug repurposing methods have limitations when gene overlap is minimal.
• Novel approaches are needed to identify effective drug candidates for diseases.

Purpose of the Study:

• To introduce a novel computational drug repurposing method called Drug Repurposing based on the Inhibition Effect (DRIE).
• To identify potential drugs for cancer treatment using an integrated gene expression and regulatory network approach.
• To overcome limitations of existing methods that rely on direct gene overlap.

Main Methods:

• DRIE integrates gene expression profiles with gene regulatory networks.
• It calculates an inhibition score using shortest path analysis within disease-specific networks.
• The method was validated on eleven independent datasets.

Main Results:

• DRIE demonstrated superior performance compared to state-of-the-art drug repurposing techniques.
• The method successfully identified novel drug-disease associations in case studies.
• Top-ranked drug candidates were validated against the Comparative Toxicogenomics Database (CTD).

Conclusions:

• DRIE provides a robust framework for computational drug repurposing, particularly for cancer.
• The method effectively identifies potential therapeutic agents for colorectal, breast, and lung cancers.
• This approach aids in annotating drug-disease relationships and accelerates drug discovery and development.